Ovarian Endometrioid Adenocarcinoma Completed Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028505 (Ovarian Endometrioid Adenocarcinoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00262847Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerTreatment